VYNE Therapeutics Inc.

VYNE

Held by 2 specialist biotech funds

Share on X

Fund Holdings

Baker Bros. Advisors

Eventide Asset Management

2 quarters

Position Trend

Aug 14, 2025

$0

0 funds

Nov 14, 2025

$285K

1 fund

Feb 13, 2026

$0

0 funds

Feb 17, 2026

$0

0 funds

-100% total institutional value over 5 quarters

Short Interest

Shorts covering

Short Shares

189K

Change

-65.6%

Days to Cover

0.6

% of Float

0.6%

Settlement

Mar 13, 2026

Short interest over 2 periods

Catalysts

No catalysts tracked.

Position Details

Baker Bros. AdvisorsEXITFeb 17, 2026

Shares: 851,353Value: $285K

Eventide Asset ManagementEXITFeb 13, 2026

Shares: 0Value: N/A

+ 4more — see how much conviction went in

See the Full Story

Know which insider moves are real

See who's buying with their own money vs. routine exercises
AI explains why each move matters right now

Start 7-Day Free Trial — $29/mo

Insider Signals

No insider signals tracked.

Also Held by These Funds

ARGX2 funds ARWR2 funds DYN2 funds IDYA2 funds INSM2 funds IONS2 funds KYMR2 funds NRIX2 funds

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Track specialist biotech funds, insider signals, and AI analysis

Start 7-Day Free Trial

Or get the free weekly brief: